|
Cellerant Therapeutics Announces Publication Confirming Activity of Myeloid Progenitor Cells in Mouse Model of Chemotherapy-Induced Neutropenia
December 7, 2004
European Patent Office Grants Cellerant Therapeutics Broad Claims on the Human Hematopoietic Stem Cell
October 28, 2004
Cellerant Therapeutics Awarded NIH Grant to Develop Human Hematopoietic Stem and Progenitor Cells for Biodefense Applications
September 29, 2004
|
